Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IMNN	IMUNON INC	$10.67M	-406.70%	-157.00%	-189.12%	17,584.70%	0.74	2.32	N/A	N/A	N/A
SEER	SEER INC	$105.51M	-26.00%	-23.10%	-26.18%	-25.90%	0.14	12.84	51.10%	-444.00%	-442.75%
LEXX	LEXARIA BIOSCIENCE CORP	$15.12M	-190.10%	-162.50%	-151.86%	-1,933.70%	0.04	26.88	100.00%	-2,589.70%	-2,588.46%
JUNS	JUPITER NEUROSCIENCES INC	$12.08M	-1,314.70%	-202.60%	468.32%	585.70%	-4.04	0.65	80.60%	-39,662.80%	-39,359.87%
SLXN	SILEXION THERAPEUTICS CORP	$1.75M	-387.80%	-144.70%	-267.20%	-522.20%	1.77	2.41	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$929.46k	N/A	-1,468.10%	253.95%	659.30%	-1.21	0.17	-1.90%	-394,725.10%	-257,168.22%
OKYO	OKYO PHARMA LTD	$62.68M	N/A	-123.50%	183.14%	79.90%	-2.36	0.58	N/A	N/A	N/A
GLPG	GALAPAGOS NV	$1.88B	16.90%	13.90%	14.43%	15.00%	0.04	30.48	97.90%	49.70%	47.97%
EXOZ	EXOZYMES INC	$81.57M	-147.20%	-105.00%	-210.32%	-334.60%	0.76	2.51	N/A	N/A	N/A
GRML	GREENLAND MINES LTD	$55.77M	-137.60%	-126.00%	-86.56%	146,924.90%	0.01	95.01	N/A	N/A	N/A
SGMO	SANGAMO THERAPEUTICS INC	$47.64M	-2,983.20%	-148.10%	-714.74%	-401.10%	-5.19	0.84	100.00%	-310.80%	-312.25%
SXTP	60 DEGREES PHARMACEUTICALS INC	$4.06M	-217.80%	-141.50%	-208.81%	-821.20%	0.57	2.66	35.70%	-1,252.60%	-1,172.67%
TTRX	TURN THERAPEUTICS INC	$112.90M	N/A	N/A	-51.86%	N/A	1.60	0.87	N/A	N/A	N/A
AEON	AEON BIOPHARMA INC	$22.77M	N/A	-394.60%	2,933.58%	-248.50%	-1.10	0.49	N/A	N/A	N/A
EVAX	EVAXION A	$36.20M	-100.20%	-37.70%	-19.12%	-44.60%	0.67	5.85	100.00%	-102.40%	-61.34%
SKYE	SKYE BIOSCIENCE INC	$28.81M	-143.60%	-119.90%	-278.09%	-354.00%	0.41	3.30	N/A	N/A	N/A
ENVB	ENVERIC BIOSCIENCES INC	$5.38M	-353.30%	-268.00%	-209.98%	1,903.70%	0.22	5.38	N/A	N/A	N/A
TCRT	ALAUNOS THERAPEUTICS INC	$6.14M	-172.70%	-123.30%	-193.96%	-529.60%	0.38	2.45	100.00%	-83,520.00%	-83,520.00%
DCOY	DECOY THERAPEUTICS INC	$3.04M	-534.50%	-239.70%	-212.58%	580.10%	0.88	2.13	N/A	N/A	N/A
DYAI	DYADIC INTERNATIONAL INC	$27.91M	-695.80%	-78.20%	-110.39%	-122.90%	7.07	2.68	24.90%	-238.30%	-223.56%
PPBT	PURPLE BIOTECH LTD	$7.67M	98.50%	83.40%	278.72%	-984.90%	0.82	1.27	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$3.02M	-241.80%	-130.20%	-204.41%	432.30%	0.75	2.39	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$190.40M	-924.30%	-161.80%	-6,444.41%	1,249.60%	220.06	0.76	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$40.04M	N/A	-56.50%	-152.46%	129.30%	10.42	1.14	71.30%	-1,300.70%	-1,300.66%
TOVX	THERIVA BIOLOGICS INC	$16.25M	-190.80%	-64.20%	-76.68%	-133.80%	1.48	1.63	100.00%	-7,656.30%	-7,153.00%
TRAW	TRAWS PHARMA INC	$22.14M	151.10%	47.60%	-1,297.73%	-117.40%	-17.88	0.72	100.00%	246.10%	246.06%
NCNA	NUCANA PLC	$0.00	-190.00%	-130.50%	-71.37%	1,079.00%	0.23	5.60	N/A	N/A	N/A
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$59.95M	-148.40%	-116.50%	-52.63%	-269.90%	0.18	3.88	N/A	N/A	N/A
TERN	TERNS PHARMACEUTICALS INC	$6.11B	-20.00%	-19.40%	-9.48%	-39.20%	0.02	62.41	N/A	N/A	N/A
VIVS	VIVOSIM LABS INC	$3.63M	-15.60%	-11.30%	-27.02%	-112.10%	0.57	2.44	100.00%	-864.10%	-853.52%
DRMA	DERMATA THERAPEUTICS INC	$5.07M	-130.90%	-102.20%	N/A	-2,531.20%	0.26	N/A	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$6.13B	-60.40%	-44.20%	-39.34%	-40.00%	0.32	9.53	N/A	N/A	N/A
TVGN	TEVOGEN BIO HOLDINGS INC	$31.15M	N/A	-623.20%	991.62%	-1,090.30%	-1.53	0.22	N/A	N/A	N/A
TVRD	TVARDI THERAPEUTICS INC	$39.21M	-64.20%	-43.90%	-106.04%	-456.50%	0.78	2.25	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$826.41k	-207.50%	-100.70%	-80.17%	383.20%	0.35	3.79	N/A	N/A	N/A
ATHE	ALTERITY THERAPEUTICS LTD	$101.36M	-47.00%	-43.30%	-26.61%	-336.80%	0.05	21.98	100.00%	-165.10%	-163.60%
CMMB	CHEMOMAB THERAPEUTICS LTD	$13.24M	-82.40%	-71.80%	-72.93%	-234.10%	0.12	9.08	N/A	N/A	N/A
VRAX	VIRAX BIOLABS GROUP LTD	$1.12M	-80.90%	-74.50%	-111.60%	-259.10%	0.12	11.35	-1,517.30%	-189,001.70%	-199,931.82%
CLRB	CELLECTAR BIOSCIENCES INC	$13.14M	-282.30%	-146.90%	-213.04%	782.90%	0.59	2.96	N/A	N/A	N/A
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$5.15M	-114.10%	-77.20%	-141.61%	-193.60%	0.77	2.53	64.80%	-484.60%	-484.56%
ENSC	ENSYSCE BIOSCIENCES INC	$3.25M	-375.00%	-195.50%	-352.09%	20,346.20%	1.42	1.59	N/A	N/A	N/A
COCP	COCRYSTAL PHARMA INC	$19.85M	-132.60%	-89.80%	-117.72%	-315.10%	0.53	3.68	N/A	N/A	N/A
VERU	VERU INC	$35.95M	-83.20%	-55.60%	-47.26%	-659.20%	0.28	5.16	N/A	N/A	N/A
SPRC	SCISPARC LTD	$2.28M	196.50%	135.60%	379.55%	686.20%	0.58	2.41	73.70%	1,422.80%	2,380.61%
VYNE	VYNE THERAPEUTICS INC	$22.03M	-74.10%	-63.30%	-95.37%	-214.70%	0.09	12.53	100.00%	-4,646.10%	-4,645.44%
XBIO	XENETIC BIOSCIENCES INC	$7.03M	-51.20%	-43.60%	-36.25%	1,048.00%	0.13	8.32	100.00%	-90.10%	-90.07%
RNAZ	TRANSCODE THERAPEUTICS INC	$6.71M	-514.50%	-76.70%	-21.67%	12,656.20%	1.02	6.29	N/A	N/A	N/A
CSBR	CHAMPIONS ONCOLOGY INC	$83.60M	-58.00%	-7.50%	-30.08%	-54.80%	5.62	0.98	45.90%	-3.90%	-4.03%
XCUR	EXICURE INC	$21.48M	-63.60%	-28.80%	-54.95%	948.40%	2.58	1.19	N/A	N/A	N/A
PMCB	PHARMACYTE BIOTECH INC	$8.12M	-22.60%	-18.00%	-6.06%	-9.70%	0.43	12.33	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$132.14M	N/A	-56.60%	-176.67%	-145.70%	-3.89	1.28	100.00%	-546.10%	-511.46%
RADX	RADIOPHARM THERANOSTICS LTD	$28.38M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
BYSI	BEYONDSPRING INC	$61.27M	N/A	-3.30%	-7.41%	-9.60%	-1.55	1.54	N/A	N/A	N/A
XRTX	XORTX THERAPEUTICS INC	$3.88M	-120.30%	-90.50%	-127.43%	-326.80%	0.29	2.11	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$14.31M	-70.30%	-35.50%	-48.82%	120.00%	0.69	0.44	N/A	N/A	N/A
BOLT	BOLT BIOTHERAPEUTICS INC	$8.97M	-92.50%	-47.10%	-69.08%	-47.00%	1.14	3.59	100.00%	-433.70%	-433.74%
EVGN	EVOGENE LTD	$6.56M	N/A	-29.70%	-39.46%	-43.70%	-98.43	4.54	-6.30%	-220.20%	-170.02%
BLRX	BIOLINERX LTD	$16.03M	-6.00%	-2.80%	0.36%	3.50%	0.97	1.95	80.50%	-99.60%	8.90%
APLM	APOLLOMICS INC	$33.93M	-1,305.40%	-110.40%	-2,801.80%	307.00%	-3.11	0.96	100.00%	-128.70%	-127.89%
XBIT	XBIOTECH INC	$75.00M	-27.80%	-26.70%	-31.81%	-224.60%	0.07	16.01	N/A	N/A	N/A
XOMA	XOMA ROYALTY CORP	$498.73M	22.50%	7.60%	13.31%	14.80%	2.01	3.37	100.00%	35.50%	60.69%
XTLB	XTL BIOPHARMACEUTICALS LTD	$6.72M	-26.80%	-18.70%	-18.24%	911.00%	0.57	0.61	0.70%	-227.70%	-256.54%
CYCN	CYCLERION THERAPEUTICS INC	$13.42M	-39.20%	-35.60%	-38.83%	-65.60%	0.10	5.15	100.00%	-170.10%	-170.11%
APLS	APELLIS PHARMACEUTICALS INC	$5.25B	39.70%	13.20%	22.37%	22.90%	1.61	3.63	90.20%	12.10%	16.17%
INM	INMED PHARMACEUTICALS INC	$2.15M	-82.00%	-69.10%	-122.64%	-668.50%	0.33	3.12	35.90%	-262.20%	-261.62%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$27.37M	-63.90%	-48.80%	-65.42%	-329.50%	0.39	6.06	N/A	N/A	N/A
YDES	YD BIO LTD	$375.89M	N/A	-67.70%	-68.50%	464.80%	-5.83	5.88	28.10%	-1,392.60%	-1,392.86%
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-64.70%	-38.70%	-51.95%	-1,148.60%	0.59	2.03	N/A	N/A	N/A
LSTA	LISATA THERAPEUTICS INC	$28.45M	-84.40%	-70.80%	-119.59%	-1,297.70%	0.21	5.77	100.00%	-9,756.50%	-10,322.35%
BCDA	BIOCARDIA INC	$12.14M	-28,372.40%	-238.20%	-838.74%	572.10%	2.81	1.12	N/A	N/A	N/A
DWTX	DOGWOOD THERAPEUTICS INC	$55.11M	-147.80%	-37.80%	-38.96%	6,048.10%	0.20	2.76	N/A	N/A	N/A
AZTR	AZITRA INC	$3.79M	-344.60%	-228.40%	-276.43%	-648.90%	0.32	2.83	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$9.90M	-1,172.90%	-162.10%	-286.88%	-194.80%	-3.05	3.58	N/A	N/A	N/A
CLLS	CELLECTIS SA	$278.51M	-69.40%	-19.50%	-9.47%	-7.40%	3.28	1.62	100.00%	-84.90%	-21.30%
BGMS	BIO GREEN MED SOLUTION INC	$4.86M	-273.20%	-230.30%	-43.65%	-471.20%	0.20	4.70	18.50%	-1,886.50%	-400.40%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$8.54M	-85.60%	-82.40%	-79.67%	4,108.20%	0.04	25.97	63.40%	-99,916.80%	-99,916.80%
APRE	APREA THERAPEUTICS INC	$11.22M	-96.30%	-74.30%	-100.63%	625.40%	0.28	5.63	100.00%	-4,409.20%	-4,637.35%
CURX	CURANEX PHARMACEUTICALS INC	$9.16M	-64.50%	-61.20%	-36.85%	-98.60%	0.03	81.94	N/A	N/A	N/A
CANF	CAN-FITE BIOPHARMA LTD	$4.60M	-178.20%	-105.50%	-144.89%	-535.10%	0.70	3.46	100.00%	-2,426.70%	-2,426.67%
ATNM	ACTINIUM PHARMACEUTICALS INC	$41.10M	-204.40%	-56.60%	-77.36%	1,156.70%	5.61	6.20	100.00%	-37,652.20%	-37,652.22%
BOLD	BOUNDLESS BIO INC	$32.35M	-53.60%	-34.70%	-42.62%	-30.60%	0.63	9.87	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$60.61M	-70.40%	-61.30%	-82.95%	1,921.70%	0.22	6.94	0.00%	-27,235.70%	-27,235.71%
BIVI	BIOVIE INC	$11.09M	-82.20%	-73.20%	-89.33%	9,178.80%	0.17	7.25	N/A	N/A	N/A
ESLA	ESTRELLA IMMUNOPHARMA INC	$53.76M	N/A	-431.00%	126.01%	158.90%	-1.31	0.12	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$4.07M	-192.40%	-152.20%	-322.04%	3,265.40%	0.85	1.99	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$5.87M	-276.60%	-140.90%	-122.81%	-540.20%	0.57	3.82	N/A	N/A	N/A
BRTX	BIORESTORATIVE THERAPIES INC	$5.25M	-420.30%	-199.40%	-3,992.21%	-892.30%	10.44	0.84	93.40%	-3,959.40%	-3,959.40%
APM	APTORUM GROUP LTD	$6.84M	-6.20%	-7.80%	-8.99%	-8.90%	0.21	0.78	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$19.83M	-85.50%	-77.40%	-36.96%	1,909.20%	0.09	11.35	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$14.67M	-38.00%	-28.00%	-21.93%	-32.70%	0.46	14.16	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$5.92M	-164.60%	-130.10%	-350.14%	2,095.30%	0.91	1.98	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$2.22M	N/A	-84.80%	-205.79%	-91.80%	7.87	0.11	100.00%	-205,593.80%	-65,597.07%
CPRX	CATALYST PHARMACEUTICALS INC	$3.80B	24.30%	21.20%	29.63%	308.40%	0.16	6.08	85.20%	36.40%	48.14%
ICCC	IMMUCELL CORP	$72.83M	-3.60%	-2.30%	-2.67%	-2.00%	0.57	4.26	41.40%	-3.80%	-3.72%
ALLR	ALLARITY THERAPEUTICS INC	$24.52M	-85.30%	-49.90%	-112.39%	234.00%	0.86	2.13	100.00%	-3,509.70%	-3,451.88%
GDTC	CYTOMED THERAPEUTICS LTD	$9.23M	-51.30%	-44.10%	-54.42%	-76.20%	0.17	5.17	100.00%	-1,227.10%	-1,220.63%
GLMD	GALMED PHARMACEUTICALS LTD	$4.02M	-57.00%	-50.40%	-70.02%	-80.70%	0.18	6.55	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$2.75M	N/A	-257.80%	2,974.21%	475.60%	-1.59	0.53	-45.50%	-15,861.40%	-14,938.64%
ADXN	ADDEX THERAPEUTICS LTD	$5.38M	-78.30%	-67.70%	-98.97%	-114.30%	0.23	2.01	100.00%	-3,845.80%	-3,843.07%
IMMP	IMMUTEP LTD	$65.73M	-61.80%	-50.90%	-83.72%	-144.80%	0.49	2.97	100.00%	-777.70%	-777.30%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 27, which is 2 points higher than the biotech industry average of 25.

JAZZ passed 9 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 129.44% over the past year, overperforming other biotech stocks by 132 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $237.67, an upside of 5.26% from Jazz Pharmaceuticals's current stock price of $225.79.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 58.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 52, which is 27 points higher than the biotech industry average of 25.

EXEL passed 17 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 31.95% over the past year, overperforming other biotech stocks by 34 percentage points.

Exelixis has an average 1 year price target of $48.00, a downside of -0.33% from Exelixis's current stock price of $48.16.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Exelixis, 14.29% have issued a Strong Buy rating, 14.29% have issued a Buy, 71.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 56, which is 31 points higher than the biotech industry average of 25.

PBYI passed 18 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 143.97% over the past year, overperforming other biotech stocks by 146 percentage points.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 18.27%, which is 14 percentage points higher than the biotech industry average of 4.3%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.11%, which is 2 percentage points higher than the biotech industry average of 4.3%.

Oramed Pharmaceuticals's dividend payout ratio of 16.3% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.77%, which is -2 percentage points lower than the biotech industry average of 4.3%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 43.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.17% in the last day, and up 2.15% over the last week. Traws Pharma was the among the top gainers in the biotechnology industry, gaining 28.24% yesterday.

Traws Pharma shares are trading higher after the company announced plans to advance potential clinical candidates for the treatment of hantavirus infections.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Rigel Pharmaceuticals has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Rigel Pharmaceuticals's stock has gained 37.78% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 65.01% in the past year. It has overperformed other stocks in the biotech industry by 67 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -9.09% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

65.08% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 61.11% over the next year.

3.09% of biotech stocks have a Zen Rating of A (Strong Buy), 3.75% of biotech stocks are rated B (Buy), 47.46% are rated C (Hold), 34.44% are rated D (Sell), and 11.26% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.13x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.